Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovirRemtricitabine/lamivudineRefavirenz administered on a multiple tablet therapy

José L. Blanco, Julio S G Montaner, Vincent C. Marconi, Maria M. Santoro, Ariel E. Campos-Loza, Robert W. Shafer, Michael D. Miller, Roger Paredes, Richard Harrigan, Mihn L. Nguyen, Carlo F. Perno, Lucero A. Gonzalez-Hernandez, José M. Gatell

Research output: Contribution to journal › Article

16 Citations (Scopus)

Abstract

Background: Fixed-dose combination antiretroviral therapy administered as a singletablet regimen (STR) may improve virologic suppression rates. The effect of STRs on development of resistance when virologic failure occurs on STRs is not known.

Original languageEnglish
Pages (from-to)2531-2539
Number of pages9
JournalAIDS (London, England)
Volume28
Issue number17
DOIs
Publication statusPublished - 2014

Fingerprint

Drug Resistance
Tablets
Mutation
Therapeutics
Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination

Keywords

  • Antiretroviral treatment
  • Atripla
  • HIV-1 resistance
  • Single-tablet regimen

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases
  • Medicine(all)

Cite this

Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovirRemtricitabine/lamivudineRefavirenz administered on a multiple tablet therapy. / Blanco, José L.; Montaner, Julio S G; Marconi, Vincent C.; Santoro, Maria M.; Campos-Loza, Ariel E.; Shafer, Robert W.; Miller, Michael D.; Paredes, Roger; Harrigan, Richard; Nguyen, Mihn L.; Perno, Carlo F.; Gonzalez-Hernandez, Lucero A.; Gatell, José M.

In: AIDS (London, England), Vol. 28, No. 17, 2014, p. 2531-2539.

Research output: Contribution to journal › Article

Blanco, JL, Montaner, JSG, Marconi, VC, Santoro, MM, Campos-Loza, AE, Shafer, RW, Miller, MD, Paredes, R, Harrigan, R, Nguyen, ML, Perno, CF, Gonzalez-Hernandez, LA & Gatell, JM 2014, 'Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovirRemtricitabine/lamivudineRefavirenz administered on a multiple tablet therapy', AIDS (London, England), vol. 28, no. 17, pp. 2531-2539. https://doi.org/10.1097/QAD.0000000000000424
Blanco JL, Montaner JSG, Marconi VC, Santoro MM, Campos-Loza AE, Shafer RW et al. Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovirRemtricitabine/lamivudineRefavirenz administered on a multiple tablet therapy. AIDS (London, England). 2014;28(17):2531-2539. https://doi.org/10.1097/QAD.0000000000000424
Blanco, José L. ; Montaner, Julio S G ; Marconi, Vincent C. ; Santoro, Maria M. ; Campos-Loza, Ariel E. ; Shafer, Robert W. ; Miller, Michael D. ; Paredes, Roger ; Harrigan, Richard ; Nguyen, Mihn L. ; Perno, Carlo F. ; Gonzalez-Hernandez, Lucero A. ; Gatell, José M. / Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovirRemtricitabine/lamivudineRefavirenz administered on a multiple tablet therapy. In: AIDS (London, England). 2014 ; Vol. 28, No. 17. pp. 2531-2539.
@article{e2d8eebf990d43ec9215052886e1571f,
title = "Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovirRemtricitabine/lamivudineRefavirenz administered on a multiple tablet therapy",
abstract = "Background: Fixed-dose combination antiretroviral therapy administered as a singletablet regimen (STR) may improve virologic suppression rates. The effect of STRs on development of resistance when virologic failure occurs on STRs is not known.",
keywords = "Antiretroviral treatment, Atripla, HIV-1 resistance, Single-tablet regimen",
author = "Blanco, {Jos{\'e} L.} and Montaner, {Julio S G} and Marconi, {Vincent C.} and Santoro, {Maria M.} and Campos-Loza, {Ariel E.} and Shafer, {Robert W.} and Miller, {Michael D.} and Roger Paredes and Richard Harrigan and Nguyen, {Mihn L.} and Perno, {Carlo F.} and Gonzalez-Hernandez, {Lucero A.} and Gatell, {Jos{\'e} M.}",
year = "2014",
doi = "10.1097/QAD.0000000000000424",
language = "English",
volume = "28",
pages = "2531--2539",
journal = "AIDS",
issn = "0269-9370",
publisher = "NLM (Medline)",
number = "17",

}

TY - JOUR

T1 - Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovirRemtricitabine/lamivudineRefavirenz administered on a multiple tablet therapy

AU - Blanco, José L.

AU - Montaner, Julio S G

AU - Marconi, Vincent C.

AU - Santoro, Maria M.

AU - Campos-Loza, Ariel E.

AU - Shafer, Robert W.

AU - Miller, Michael D.

AU - Paredes, Roger

AU - Harrigan, Richard

AU - Nguyen, Mihn L.

AU - Perno, Carlo F.

AU - Gonzalez-Hernandez, Lucero A.

AU - Gatell, José M.

PY - 2014

Y1 - 2014

N2 - Background: Fixed-dose combination antiretroviral therapy administered as a singletablet regimen (STR) may improve virologic suppression rates. The effect of STRs on development of resistance when virologic failure occurs on STRs is not known.

AB - Background: Fixed-dose combination antiretroviral therapy administered as a singletablet regimen (STR) may improve virologic suppression rates. The effect of STRs on development of resistance when virologic failure occurs on STRs is not known.

KW - Antiretroviral treatment

KW - Atripla

KW - HIV-1 resistance

KW - Single-tablet regimen

UR - http://www.scopus.com/inward/record.url?scp=84927774765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927774765&partnerID=8YFLogxK

U2 - 10.1097/QAD.0000000000000424

DO - 10.1097/QAD.0000000000000424

M3 - Article

C2 - 25574957

AN - SCOPUS:84927774765

VL - 28

SP - 2531

EP - 2539

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 17

ER -

Access to Document